인쇄하기
취소

Omacor patents are valid until 2020, Kuhnil says

Published: 2012-07-31 06:56:00
Updated: 2012-07-31 06:56:00
Kuhnil Pharmaceutical has recently confirmed that the Korean patents for Omacor (omega-3-acid ethyl esters), which has been also sold under the brand name of Lovaza in the U.S., are valid until February 2020 as an U.S. Delaware court ruled in favor of a Norwegian company Pronova BioPharma (upholding two patents for its heart drug Omacor against the US subsidiary of Israeli generics giant Teva P...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.